Stay updated on Emixustat in Stargardt Macular Atrophy Clinical Trial

Sign up to get notified when there's something new on the Emixustat in Stargardt Macular Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Emixustat in Stargardt Macular Atrophy Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:20:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T06:05:10.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:22:09.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page has undergone significant content removal related to a pharmacodynamics study of emixustat hydrochloride for Stargardt disease, including detailed descriptions of the study's design, criteria, and investigators. The only notable addition is a reference to the study's version revision.
    Difference
    26%
    Check dated 2025-04-16T10:35:43.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:28:07.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-03-03T22:56:51.000Z thumbnail image

Stay in the know with updates to Emixustat in Stargardt Macular Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Emixustat in Stargardt Macular Atrophy Clinical Trial page.